You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

Details for New Drug Application (NDA): 019839


✉ Email this page to a colleague

« Back to Dashboard


NDA 019839 describes ZOLOFT, which is a drug marketed by Viatris and is included in two NDAs. It is available from three suppliers. Additional details are available on the ZOLOFT profile page.

The generic ingredient in ZOLOFT is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.
Summary for 019839
Tradename:ZOLOFT
Applicant:Viatris
Ingredient:sertraline hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019839
Medical Subject Heading (MeSH) Categories for 019839
Suppliers and Packaging for NDA: 019839
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOLOFT sertraline hydrochloride TABLET;ORAL 019839 NDA ROERIG 0049-4900 0049-4900-30 30 TABLET, FILM COATED in 1 BOTTLE (0049-4900-30)
ZOLOFT sertraline hydrochloride TABLET;ORAL 019839 NDA ROERIG 0049-4900 0049-4900-41 100 BLISTER PACK in 1 CARTON (0049-4900-41) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 50MG BASE
Approval Date:Dec 30, 1991TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 100MG BASE
Approval Date:Dec 30, 1991TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Dec 30, 1991TE:RLD:Yes

Expired US Patents for NDA 019839

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-002 Dec 30, 1991 ⤷  Sign Up ⤷  Sign Up
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 ⤷  Sign Up ⤷  Sign Up
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-005 Mar 6, 1996 ⤷  Sign Up ⤷  Sign Up
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-004 Dec 30, 1991 ⤷  Sign Up ⤷  Sign Up
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 ⤷  Sign Up ⤷  Sign Up
Viatris ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.